Kolexia
Adiko Didier Hématologie
Adiko Didier
Hématologie
Centre Hospitalier Libourne
Libourne, France
67 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie myéloïde chronique BCR-ABL positive Leucémie myéloïde Myélome multiple Aberrations des chromosomes Surcharge en fer Récidive tumorale locale Leucémie aigüe myéloïde Syndromes myéloprolifératifs

Collaborateurs

Voir plus
Laboure Gaelle
Laboure Gaelle
Centre Hospitalier Libourne, Libourne, France
Schmitt Anna
Schmitt Anna
Institut Bergonié, Bordeaux, France
Lara Diane
Lara Diane
Centre Hospitalier Libourne, Libourne, France
Hulin Cyrille
Hulin Cyrille
Hôpital Haut-lévêque, Pessac, France

Industries

Voir plus
A+A
100 collaboration(s)
Dernière en 2023
IQVIA
72 collaboration(s)
Dernière en 2022
B3TSI
53 collaboration(s)
Dernière en 2023
Novartis
23 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   07 novembre 2022
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present from the Diagnosis in Tiny Undetectable Subclones
Blood   23 novembre 2021
Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors.
Cancer medicine   14 mai 2021
Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients.
Cancers   04 septembre 2020
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk.
Haematologica   01 septembre 2020
Clinical Spectrum, Long-Term Outcomes and Predictors of Relapse after Imatinib Discontinuation in FIP1L1-Pdgfra-Associated Chronic Eosinophilic Leukemia: Data from 150 Patients
Blood   13 novembre 2019
Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload.
European journal of haematology   02 mai 2018
Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study.
American journal of hematology   12 janvier 2018
Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-Dependent Patients with Low-Risk MDS and Iron Overload: The Rythmex Study
Blood   01 janvier 2016
ELN 2013 response status criteria: relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?
American journal of hematology   25 octobre 2014